Memorial Bahçelievler Hospital
The cost of polycystic kidney disease treatment in Turkey varies depending on the specific procedures and evaluations required. A kidney transplant with a related donor costs approximately $20,000, while the same procedure with unrelated donors ranges from $18,000 to $27,000. Initial examinations and tests, such as detailed blood tests, abdominal CT scans, and nephrology consultations, can cost up to $1,500. Additional consultations for managing ongoing kidney issues are priced at around $150. Each treatment plan is tailored to the patient"s unique medical needs and condition severity.
| Turcja | Austria | Hiszpania | |
| Terapia objawowa | od $300 | od $700 | od $800 |
Dr Bugra Cetin specjalizuje się w zaawansowanych metodach leczenia urologicznego, w tym w innowacyjnych terapiach komórkowych w przypadku złożonych schorzeń. Praktykuje w szpitalu Bahçelievler Medicalpark.
Doc. dr Basri Cakiroglu specjalizuje się w leczeniu wielotorbielowatości nerek w szpitalu Hisar Intercontinental. Posiada wiedzę ekspercką w zakresie endourologii i uroonkologii.
Lekarz jest onkologiem urologicznym specjalizującym się w chirurgii małoinwazyjnej, rekonstrukcji nowego pęcherza i raku urologicznym w Anadolu Medical Center. Posiada tytuł licencjata Uniwersytetu Stambulskiego oraz rezydenturę z urologii na Uniwersytecie Marmara. Lekarz został wyróżniony kilkoma nagrodami, w tym Nagrodą Zachęty Naukowej dla Rezydentów w 2008 roku oraz Nagrodą za Młodą Prezentację Akademicką w 2012 roku.<\/p>
Lekarz jest członkiem zarządu wykonawczego Stowarzyszenia Uroonkologii i sekretarzem Grupy Badawczej ds. Guzów Pęcherza. Ponadto lekarz jest członkiem Międzynarodowej Sieci Raka Pęcherza, Europejskiego Stowarzyszenia Urologii oraz Amerykańskiego Kolegium Chirurgów.<\/p>
Profesor Abdulmuttalip Simsek specjalizuje się w urologii robotycznej i rekonstrukcyjnej w szpitalu Memorial Bahçelievler.
Treatment options for polycystic kidney disease in Turkey include medical management, cyst decompression, and organ transplantation. JCI-accredited facilities utilize robotic systems like the Da Vinci for precision surgeries. Advanced therapies like Tolvaptan help slow kidney function decline. Expert nephrologists manage blood pressure and fluid intake to preserve renal health.
Bookimed Expert Insight: Turkish hospitals like Anadolu Medical Center benefit from international affiliations with institutions like Johns Hopkins. This drives a high volume of complex cases, such as over 65,000 annual patients. Selecting JCI-accredited clinics in Istanbul ensures access to surgeons with experience in thousands of robotic procedures. These high-volume centers often achieve better precision in nephrectomies and transplants.
Patient Consensus: Patients emphasize the value of lining up living donor testing early. They also note that getting pain interventions like cyst aspiration can delay the need for major surgery.
Tolvaptan therapy is available for ADPKD patients at specialized medical centers in Turkey. The Turkish health authorities have approved the medication for adults with rapidly progressing polycystic kidney disease. Licensed centers manage the mandatory liver monitoring. Treatment requires clear clinical criteria and specialist supervision.
Bookimed Expert Insight: Turkish specialists emphasize that Tolvaptan therapy requires long-term commitment beyond the initial prescription. Our data shows that top Istanbul facilities, which serve over 250,000 patients annually, integrate the mandatory liver monitoring into standard follow-up care. Choosing a large center like Hisar Hospital Intercontinental ensures the specialized diagnostic infrastructure remains available for the full 18-month monitoring period.
Patient Consensus: Patients note that organizing the required monthly liver tests is the most challenging part of therapy. Reviewers appreciate the hospital assistance with translations and airport logistics, which simplifies the frequent medical visits needed for monitoring.
Turkish centers report kidney transplantation success rates between 94% and 99% for 1-year graft survival. National data indicates 1-year survival reaches 96% for living-donor transplants and 86% for deceased-donor cases. Major Istanbul hospitals maintain 5-year graft survival rates above 90% for living-donor kidneys.
Bookimed Expert Insight: Success rates for complex cases stay high because Turkish facilities like Memorial Sisli achieve a 90% organ transplant success rate while serving patients from 167 countries. This high volume across JCI-accredited centers ensures surgeons maintain peak proficiency in donor matching and robotic-assisted nephrectomy.
Patient Consensus: Patients highlight that living-donor swap programs in Turkey allow for faster procedures compared to long international waitlists. They emphasize choosing major hospitals over smaller centers to ensure smooth recovery and thorough pre-operative matching.
Internationally accredited hospitals for polycystic kidney disease (PKD) work-up and transplant surgery must hold Joint Commission International (JCI) certification. Premier centers in Turkey, such as Memorial Sisli and Anadolu Medical Center, maintain these standards. These facilities offer specialized nephrology teams and high organ transplant success rates.
Bookimed Expert Insight: Patient volume often signals surgical precision in complex PKD cases. Our data shows Hisar Hospital Intercontinental serves over 500,000 patients annually. High-volume centers like this frequently manage the anatomical challenges of enlarged PKD kidneys more effectively than smaller clinics.
Patient Consensus: Patients note that JCI-accredited hospitals like Memorial and Anadolu provide smooth diagnostic processes. They emphasize that these centers handle complex PKD cases with standards often rivaling those in the United States.
Turkish centers coordinate long-term care for polycystic kidney disease through specialized international departments and digital health platforms. JCI-accredited facilities provide multidisciplinary teams including nephrologists and urologists who manage follow-up. Care shifts from acute interventions to remote monitoring using digital clinical summaries and scheduled telehealth consultations.
Bookimed Expert Insight: While many seek Turkey for acute interventions, the high volume of international patients—up to 250,000 yearly at centers like Hisar Intercontinental—has forced a shift toward digital-first follow-up. The most effective coordination happens when patients choose hospitals with established affiliations, such as Anadolu Medical Center’s partnership with Johns Hopkins Medicine. This specific link often simplifies the transfer of complex medical records between Turkey and home-country specialists for long-term PKD monitoring.
Patient Consensus: Patients note that regular email check-ins every 3 months and WhatsApp groups with surgeons are vital for quick queries. They emphasize securing a detailed discharge summary in Turkey to ensure their local nephrologist can maintain treatment continuity.
Turkish urologists treat massively enlarged polycystic kidneys primarily through minimally invasive native nephrectomy. Surgeons utilize advanced laparoscopic and robotic platforms to remove the kidney through small keyhole incisions. These techniques reduce surgical trauma compared to open procedures and accelerate overall recovery time.
Bookimed Expert Insight: Anadolu Medical Center performs approximately 65,000 procedures annually and benefits from a strategic affiliation with Johns Hopkins Hospital. Our data shows that top Turkish specialists like Dr. Ilker Tinay and Dr. Tuncay Tas emphasize preoperative cyst mapping. This step is critical because precise imaging allows surgeons to plan the aspiration of specific cysts. Navigating the distorted anatomy caused by massive enlargement becomes safer and more predictable for the patient.
Patient Consensus: Patients note that laparoscopic cyst decortication provides significant relief and helps delay the need for dialysis. Many emphasize the importance of budgeting time for travel fatigue after being discharged quickly from Istanbul clinics.
Patients transition to transplant listing when their estimated glomerular filtration rate falls to 20 mL/min/1.73 m2 or below. Doctors also consider rapid progression markers like high total kidney volume and chronic complications. These include intractable pain or infections that do not respond to medication.
Bookimed Expert Insight: Clinics like Hisar Hospital Intercontinental report a 90% organ transplant success rate. Our data shows Turkish centers often prefer evaluating patients when filtration rates hit 25 mL/min/1.73 m2. This early start allows JCI-accredited facilities to identify living donors and prepare for complex native nephrectomies if kidneys are too large.
Patient Consensus: Patients emphasize tracking kidney size early because massive enlargement often forces a transplant sooner than filtration numbers alone suggest. Many note that high-level expertise, like that found at Memorial Bahçelievler Hospital, makes the transition from conservative care much smoother.